openPR Logo
Press release

Glucosamine Market Value Projected to Expand by 2018 to 2028

08-10-2018 04:00 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Glucosamine Market Value Projected to Expand by 2018 to 2028

Glucosamine Market Introduction:

Glucosamine is a naturally occurring compound within the cartilage of joints, it is made from chains of sugars and proteins bound together. Glucosamine is processed from shellfish that has been found to provide relief from minor pain. This naturally derived compound helps in formation of cartilage and synovial fluid which helps in maintaining joint health. Glucosamine is primarily used to ease symptoms of osteoarthritis, it can be taken by natural food supplements such as bone broth or glucosamine supplements available in the market in numerous formulations. Apart from its therapeutic use glucosamine is also used in cosmetic products, as it supports formation of connective tissue and helps increasing moisture and promotes exfoliation and hydration. These fundamental properties of glucosamine have encouraged the manufacturers to introduce new products and thus leading to overall growth of glucosamine market.

Glucosamine plays a vital role in cartilage building, supplement to treat arthritis and osteoarthritis.

Glucosamine is segmented on the basis of form and end use. The use of glucosamine is not just limited to pharmaceutical product for relief from joint pain but is also used as an ingredient in cosmetics due to its skin-replenishing property and prompting exfoliation. On the basis of form glucosamine is segmented as; powder, liquid, tablets, capsules and others (gel). It is also segmented by end use as pharmaceutical and as additive, which is further sub-segmented as pet-food additive and cosmetics. Glucosamine is suggested for joint problems and is one of the most common dietary supplements for both humans and pets use. Pet food manufacturers have added glucosamine to provide further joint support especially for older dogs or large pets.

Request for Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1376

Glucosamine Market Regional Outlook:

On the basis of regions, the glucosamine market is segmented into North America, Europe, Latin America, Asia-Pacific excluding Japan, Japan, CIS & Russia, Middle East & Africa.
The glucosamine market is very prominent in European countries, as an over-the-counter or prescription medication. Glucosamine is either subsidized or reimbursed by certain insurers or some government health plans which is not the same U.S.

With a higher prevalence of osteoarthritis in developed countries, glucosamine finds a higher recommendations for treatment of Osteoarthritis in European countries as well as U.S., Canada and Australia. Even though high quality studies for glucosamine and its effectiveness still does not hold a strong ground certain consumers have valued glucosamine to be better than other alternatives available which is due to the fact that glucosamine has been found to be as safe as placebo with very few side effects compared to some other pharmaceutical medications for osteoarthritis.

Glucosamine Market: Key Developments

Substantial application of glucosamine in cosmetic products; Olay launched eyes illuminating eye cream for dark circles under eyes a range of products for its eye Olay eyes segment. The product features use of amino peptides and N-Acetyl glucosamine for reduction of dark circles.

Continuing use for improving bone health with synergistic compounds; Xango a multilevel marketing company, launched its Aeris marine collagen complex to boost its product portfolio. The product consists of hydrolyzed marine collagen peptides with glucosamine to promote healthy skin, hair, joints and bones.

Increasing use of glucosamine in pet food; in 2016, Nootie, which is a supplier of health products for pets, launched its new product “Progility” which is a chewable treat for dogs. The product features glucosamine, providing relieve from joint pain and sustaining immune health.

Benefit Natural which is a raw dog food manufacturer has announced the launch of its Benefit Mini Range, with added Glucosamine and Chondroitin in the senior dog foods for healthy joints.

Glucosamine Market Key Players:

Some of the key players participating in the global Glucosamine market includes; Mylan N.V., Teva Pharmaceutical Industries Ltd., Nutralife Health Products Inc., Blackmores Ltd., G.T.C. Union Group Ltd., Foodchem International Corporation, Health World Ltd., Glanbia plc., NOW Health Group, Inc.

Opportunities for Glucosamine Market Participants:

The global Glucosamine market is looking promising for the period 2017-2028. The potential for the growth of the Glucosamine market is quite high, According to the National Center for Complementary and Alternative Therapy, a 2007 National Health Interview Survey, found that 17.7% of adults in the United States regularly consumed some type of dietary supplement. From which, 19.9 % took glucosamine. It was the second most popular dietary supplement after fish oil, omega 3, or DHA, which were consumed 37.45 of those who took supplements.

Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=1376

Brief Approach to Research:

A modeling-based approach and triangulation methodology will be followed to estimate data covered in this report. A detailed market understanding and assessment of the applications, types, forms, and end uses of the product segments included in the study is followed by carrying out a demand-side approach to estimate the sales of target product segments, which is then cross-referenced with a supply-side assessment of value generated over a pre-defined period. The statistics and data are collected at a regional level, consolidated and synthesized at a global scale to estimate the overall market sizes.

Key Data Points Covered in the Report:

An overview of the global Glucosamine market including background and advancement.
Macroeconomic factors affecting the Glucosamine market and its potential.
Market dynamics, such as drivers, challenges, and trends
Detailed value chain analysis of the Glucosamine market
The cost structure of the Glucosamine and segments covered in the study
In-depth pricing analysis, by crucial Glucosamine segments, regions and by major market participants
Analysis of supply and demand, such as top producing and consuming geographies, imports/exports, and overall trade scenario
Analysis of the market structure, including a tier-wise categorization of key market participants
Competitive landscape of the market, including detailed profiles of the top players in this market
This analytical research study imparts an all-inclusive assessment on the market, while propounding historical intelligence, actionable insights, and industry-validated & statistically-upheld market forecast. Verified and suitable set of assumptions and methodology has been leveraged for developing this comprehensive study. Information and analysis on key market segments incorporated in the report has been delivered in weighted chapters. A thorough analysis has been offered by the report on

Market Dynamics
Market Size
Market Segments
Demand & Supply Trends
Current Issues and Challenges
Companies and Competitor Landscape
Value Chain
Technology
Regional Segments Analyzed Include

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)
Compilation of authentic and first-hand intelligence, insights offered in the report are based on quantitative and qualitative assessment by leading industry experts, and inputs from opinion leaders & industry participants around the value chain. Growth determinants, macroeconomic indicators, and parent market trends have been scrutinized and delivered, coupled with the market attractiveness for each market segment encompassed. Qualitative impact of growth influencers on the market segments across regions has also been mapped by the report.

Highlights from the Report

Elaborated scenario of the parent market
Transformations in the market dynamics
Detailed segmentation of the target market
Historical, current and forecast market size based on value and volume
Latest industry developments and trends
Competition landscape
Strategies adopted by the market players and product developments made
Potential and niche segments, along with their regional analysis
Unbiased analysis on performance of the market
Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glucosamine Market Value Projected to Expand by 2018 to 2028 here

News-ID: 1174021 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Glucosamine

Glucosamine Prices, Pricing Report, Trends, Monitor | IMARC Group
North America Glucosamine Prices the Q4: Glucosamine Prices in United States: In United States see, Glucosamine Prices plummeted to about 7,200 USD/MT in December 2024 on global supply chain stabilization and stock building by strategic stockpiling through China's Golden Week. As Chinese exporters drove lower pricing Glucosamine Price Trend reversed to down, U.S. producers reduced their stock positions to more match-market conditions. The market getting softer again as logistics and labor issues
Glucosamine Prices Influence by Seasonal Demand & Supply Shifts
North America Glucosamine Prices the Q4 2024: Glucosamine Prices in United States: In December 2024, Glucosamine prices in the United States saw a notable drop, falling to 7,200 USD/MT. This decline was mainly attributed to strategic stockpiling ahead of China's Golden Week and the stabilization of supply chains. As Chinese exporters began to present more competitive pricing and U.S. suppliers concentrated on lowering their inventory, the market turned more favorable for buyers,
Glucosamine Market Size, Share, Growth 2031
Glucosamine Market Size was estimated at USD 241.2 million in 2021 and is projected to reach USD 317.4 million by 2028, exhibiting a CAGR of 4% during the forecast period. The Glucosamine Market 2024 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research
Global Glucosamine Market Report - Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Glucosamine Market is projected to grow at a CAGR of 3.2% from 2021 to 2026. The major factors expected to be the drivers of market growth include the increasing number of arthritis patients, boosting desk-bounded working style in developing as well as developed nations, growing prevalence of obesity, and the rising consumption of dietary supplements. The major
Glucosamine Market Compute in High Growing Sectors
The global glucosamine market include various different product types such as powder, tablets, capsules and liquids. Glucosamine is naturally synthesized in the human body, used as a health supplement and can be used in the treatment of various conditions such as rheumatoid arthritis, asthma, inflammatory bowel diseases, joint pain, allergies, chronic venous insufficiency, sports injuries, temporomandibular joint problems (TMJ), and long-term low back pain. Request Free Sample Report of Glucosamine Market
Glucosamine Sulfate Market to Witness Robust Expansion by 2025
Market Research Report Store offers a latest published report on Glucosamine Sulfate Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Glucosamine Sulfate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/1033224/global-glucosamine-sulfate-market-insights Glucosamine